![Pfizer-BioNTech Vaccine Shows Good Response Against New COVID Strain](https://cloutnews.com/wp-content/uploads/2023/06/DailyMotion-Banner.jpg)
Pfizer-BioNTech Vaccine Shows Good Response Against New COVID Strain
The coronavirus vaccine developed by Pfizer-BioNTech is likely to be just as effective against a highly transmissible mutant strain of the virus that was discovered in the U.K., according to a study by the two companies.
The variant, known as B.1.1.7., was estimated to have first emerged in the U.K. in September. It has an unusually high number of mutations and is associated with more efficient and rapid transmission.
The New COVID Variant
The characteristics of the variant had led to concerns about the effectiveness of Covid vaccines against it. However, research published on preprint server bioRxiv showed “no biologically significant difference in neutralization activity” between the laboratory tests on B.1.1.7 and the original strain of the coronavirus.
The study, which has not yet been peer-reviewed, found that all of the mutations associated with the newly discovered variant were neutralized by antibodies in the blood of 16 participants who had previously been given the vaccine.
Vaccine Trials
Half of the participants were ages 18 to 55 and the other half were 56 to 85.
Authors of the study warned that the rapid spread of Covid variants worldwide required “continuous monitoring of the significance of changes for maintained protection by currently authorized vaccines.”
It is the first paper of its kind to be completed by a major Covid vaccine maker. Other drug companies are scrambling to conduct tests on the effectiveness of their own respective inoculations.
Moderna and AstraZeneca, which has developed a Covid vaccine in partnership with the University of Oxford, have said they expect their vaccines to be effective against B.1.1.7.
Quicker Transimission
Earlier this month, Dr. Ugur Sahin, co-founder and CEO of BioNTech, told CNBC that the German pharmaceutical company was confident its vaccine would develop an immune response against B.1.1.7.
Sahin said the vaccine also should prove to be effective against a variant discovered in South Africa — another highly transmissible mutation that has raised concerns.
His comments came shortly after initial tests had shown Pfizer-BioNTech’s Covid-19 vaccine appeared to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K. and South Africa. Now, scientists from the two companies have published research indicating the vaccine is likely to be effective against all mutations associated with B.1.1.7.
Recent Posts
- Pakistan Opens Doors to Boost Tourism and Business with Free Visas for 126 Countries
- Disney’s “Inside Out 2” Becomes the Highest-Grossing Animated Film Ever
- South Korea Cracks Down on Crypto Exchange Fees
- Ava Kris Tyson Departs MrBeast Following Grooming Allegations
- Apple’s iPhone SE 4: What do we know so far?
- ‘Inside Out 2’ Crushes Box Office and Enters the Billion-Dollar Club
- Telegram Founder Backs Viral Crypto Game Hamster Kombat, Calls it a New Era for Blockchain
- End of the Road for Self-Lacing Nikes: App Shutdown Leaves Adapt BB Owners with Limited Functionality
- Chaotic Encounter During European Tour Leaves IShowSpeed Injured and Frightened
- Quirky RPG ‘Thirsty Suitors’ Coming Soon to Mobile on Netflix Games